European Commission suspects pharma group Teva broke antitrust rulesMarketing & Advertising, TherapeuticsThe European Commission informed Teva Pharmaceutical of its preliminary view that the company breached European Union (EU) antitrust rules with practices aimed at delaying competition to multiple sclerosis product Copaxone. Read more October 10, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2021/06/New-York-takes-Teva-McKesson-others-to-trial-over-opioids-Reuters-6-29-21.jpg 503 960 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-10-10 04:40:572022-10-10 08:57:47European Commission suspects pharma group Teva broke antitrust rules
